Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort

Recruiting · NCT04375280 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital, Clermont-Ferrand

View the official record on ClinicalTrials.gov →

COPD Obesity Osteoarthritis

Interventions studied

Development of a screening algorithm designed to determine a "dysmobility" profile in patients with chronic illness.

What this trial is about

Chronic illness is a public health issue and mobility loss is frequent in this population. Among its' multiple physical and psychological consequences, increased mortality and cardiovascular morbidity seem the main concern. Therefore, the exploration of locomotor deficiencies, physical capacities and metabolism of patients with chronic illnesses constitutes a major challenge both for the treatment of causal pathologies, as well as for evaluating the impact of therapeutic interventions, the benefit of which will be an improvement in physical capacities and ultimately mobility. In view of the hypothesis of an increase in the prevalence of mobility disorders in this population, this approach is part of a logic of screening and improving the effectiveness of the care of these patients with a multidisciplinary evaluation of individual risks. The EVALMOB protocol was designed in order to try to determine a standard profile of "dysmobility" in patients with chronic illness

Who can take part

Age range

18 Years to 90 Years

Sex

All (male and female)

Healthy volunteers

No - a diagnosis or condition is required

Phase

Not applicable (e.g. observational or device study)

Study type

Interventional (participants receive a specific treatment)

Inclusion criteria

Man or woman aged 18 to 90.
Patients with chronic pathology contributing to impaired mobility.
Volunteers who have given their written consent.
Affiliated to French health care system (for France)

Exclusion criteria

Patients suffering from progressive psychiatric pathologies (active psychosis, hallucinations, etc.) or the presence of another serious unstabilized pathology (decompensated heart failure, progressive terminal cancer, etc.).
People with poorly controlled or unstable cardiovascular disease.
Major osteoarticular or neurological problems completely preventing the proper performance of the various tests.
Non-autonomous patient
Persons under guardianship, curatorship, deprived of liberty or safeguarding justice.
People excluded from another study.
Pregnant or lactating women.

Where it is running

3 locations listed.

Chu Clermont Ferrand - Clermont-Ferrand, France
Chu Clermont Ferrand - Clermont-Ferrand, France
Chu Clermont Ferrand - Clermont-Ferrand, France

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →